Retour
Fourchette du Jour
21,42 €
23,62 €
Fourchette 52 Semaines
1,92 €
31,18 €
Volume
745 778
Moyenne 50J / 200J
25,15 €
/
16,46 €
Clôture Précédente
21,85 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -6,8 | 0,2 |
| P/B | 8,0 | 3,0 |
| ROE % | -84,7 | 3,6 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 9,9 |
| D/E | 0,5 | 0,2 |
Objectif de Cours des Analystes
Hold
44,00 €
+93.4%
Low: 38,00 €
High: 50,00 €
BPA Prévisionnel
-3,73 €
CA Est.
11,32M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
0,43 €
0,43 € – 0,43 €
|
431,34M | 1 |
| FY2028 |
-1,42 €
-1,42 € – -1,42 €
|
213,35M | 1 |
| FY2027 |
-3,48 €
-3,99 € – -3,25 €
|
51,22M | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-11-13 | -1,07 € | -1,16 € | -8,4% |
| 2025-08-13 | -1,01 € | -1,03 € | -2,0% |
| 2025-05-14 | -0,89 € | -1,09 € | -22,5% |
| 2025-03-27 | -0,90 € | -0,84 € | +6,7% |
| 2024-11-14 | -0,90 € | -0,84 € | +6,7% |
| 2024-08-14 | -0,87 € | -0,86 € | +1,1% |
| 2024-05-15 | -1,09 € | -0,82 € | +24,8% |
| 2024-03-28 | -0,86 € | -1,13 € | -31,4% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Debt/Equity of 0,47 — conservative balance sheet
Negative free cash flow of -117,72M
PEG of 0,09 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-84,70%
ROIC-63,52%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,47
Current Ratio6,72
Interest Coverage0,00
Valorisation
P/E Ratio
-6,83
Forward P/EN/A
P/B Ratio8,01
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -176,21M |
| ROE | -84,70% | ROA | -52,51% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -117,72M |
| ROIC | -63,52% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,47 | Current Ratio | 6,72 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -6,83 | Forward P/E | N/A |
| P/B Ratio | 8,01 | P/S Ratio | N/A |
| PEG Ratio | 0,09 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 106,37 | Fwd Earnings Yield | N/A |
| FCF Yield | -9,78% | ||
| Market Cap | 1,20B | Enterprise Value | 1,11B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -176,21M | -260,49M | -333,82M | -266,99M | -133,10M |
| EPS (Diluted) | -3,35 | -4,97 | -6,39 | -5,16 | -2,91 |
| Gross Profit | -26,71M | -25,95M | -11,00M | -8,71M | -4,21M |
| Operating Income | -186,85M | -277,32M | -341,38M | -267,05M | -136,01M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 335,58M | 479,37M | 666,63M | 904,22M | 1,07B |
| Total Liabilities | 185,29M | 213,59M | 230,46M | 240,90M | 206,60M |
| Shareholders' Equity | 150,29M | 265,78M | 436,17M | 663,32M | 860,75M |
| Total Debt | 70,35M | 181,63M | 187,73M | 179,94M | 77,40M |
| Cash & Equivalents | 168,07M | 285,51M | 190,43M | 731,51M | 944,40M |
| Current Assets | 171,94M | 289,31M | 486,01M | 734,81M | 972,01M |
| Current Liabilities | 25,57M | 41,73M | 52,50M | 64,68M | 31,42M |